# Assessment of thiamine status and its association with clinical parameters in patients undergoing maintenance hemodialysis

**Authors:** Bo Yang, Naiying Lan, Fanzhou Zeng, Qing Shao, Dan Ye, Hao Wang, Cheng Xue, Nanmei Liu

PMC · DOI: 10.3389/fnut.2025.1563768 · Frontiers in Nutrition · 2025-05-14

## TL;DR

This study found that thiamine deficiency is common in hemodialysis patients and linked to anemia and iron metabolism markers.

## Contribution

The study identifies a novel association between thiamine levels and anemia in hemodialysis patients.

## Key findings

- Thiamine deficiency was present in 11.5% of hemodialysis patients.
- Thiamine levels correlated positively with hemoglobin, transferrin saturation, and serum iron.
- Thiamine levels were independently associated with hemoglobin levels in multivariate analysis.

## Abstract

Thiamine deficiency is a common complication in end-stage renal disease (ESRD) patients receiving maintenance hemodialysis (HD). The purpose of this cross-sectional study was to assess the prevalence of thiamine deficiency in HD patients and its association with clinical parameters.

This was a single-center cross-sectional study that included 113 maintenance HD patients from our hospital. Thiamine status was evaluated by high-performance liquid chromatography on whole blood samples. We evaluated the association between blood thiamine concentration and other clinical parameters, including markers of iron metabolism and cardiac function.

The prevalence of thiamine deficiency was 11.5%. Univariate analysis revealed a significant positive correlation between thiamine levels and iron metabolism markers, including hemoglobin level (Rho = 0.257, p = 0.006), transferrin saturation (Rho = 0.244, p = 0.009), and serum iron (Rho = 0.213, p = 0.025). A multivariate regression analysis confirmed that thiamine levels were independently associated with hemoglobin levels (beta coefficients = 0.25, p = 0.012).

These findings suggest an association between lower thiamine levels and anemia in HD patients. Further research is needed to elucidate the underlying mechanisms and evaluate the efficacy of thiamine supplementation in improving anemia and other clinical outcomes in this population.

## Linked entities

- **Chemicals:** thiamine (PubChem CID 1130)
- **Diseases:** end-stage renal disease (MONDO:0004375), anemia (MONDO:0002280)

## Full-text entities

- **Genes:** TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}
- **Diseases:** ESRD (MESH:D007676), anemia (MESH:D000740), Thiamine deficiency (MESH:D013832)
- **Chemicals:** iron (MESH:D007501), Thiamine (MESH:D013831)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12118120/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12118120/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12118120/full.md

---
Source: https://tomesphere.com/paper/PMC12118120